Financials
Financial year 2026
DL PHARMA + from Zulte, company number BE0755325637, closed financial year 2026 with a result of € 84 after tax. For that financial year DL PHARMA + recorded a gross margin of € 2,228 and equity of € 11,109. Compared with financial year 2025, the result moved from € -13,921 to € 84. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 10, 2026.
€ 11,109
▲ 1% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 84
▲ still € 13,921 loss in 2025
Profit after tax over the fiscal year.
€ 12,442
▲ 47% vs 2025
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2026. Retained profit grew to € 6,109.
People and assets in 2026
€ 1,011
▼ 53% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 820
▼ 69% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 3,988
▼ 32% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 7,009 | € 9,265 | € -12,041 | € 2,228 | ▲ € 14,269 |
| Profit after taxes | € 4,727 | € 5,550 | € -13,921 | € 84 | ▲ € 14,006 |
| Equity | € 19,397 | € 24,947 | € 11,025 | € 11,109 | ▲ 1% |
| Total debts | € 12,992 | € 11,778 | € 10,208 | € 7,557 | ▼ 26% |
| Cash | € 22,933 | € 25,824 | € 8,486 | € 12,442 | ▲ 47% |
| Retained profit | € 14,397 | € 19,947 | € 6,025 | € 6,109 | ▲ 1% |
| Balance sheet total | € 32,388 | € 36,725 | € 21,233 | € 18,667 | ▼ 12% |
By gross margin, DL PHARMA + ranks 4th of 4 companies with main activity “Detailhandel in farmaceutische producten” in Zulte that publish figures (fiscal year 2026).
Key figures of DL PHARMA +, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
Ask about DL PHARMA + the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to DL PHARMA +?
What happened at DL PHARMA + in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 84. Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Zulte. KBO
In short
From € 4,727 profit in 2023 to € 84 profit in 2026.
Paid € 3,411 in corporate taxes since 2023.
Best year ever: 2024, with € 5,550 profit.
Establishments
Establishment units
Physical locations of this company
Boswegel 27
9870 Zulte
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Zulte
Same main activity (Detailhandel in farmaceutische producten), 4 active companies in Zulte, largest first.
€ 814,793 gross margin · 2025
€ 583,100 gross margin · 2025
€ 244,606 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- DE LOENZIEN Elke Cecile Joël(oprichter) 100%
Details
- Company number
- 0755.325.637
- VAT number
- BE 0755.325.637
- Registered office
- Boswegel 27, 9870 Zulte
- Names & denominations
- DL PHARMA +
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 September 2020
- Peppol
- Active · Active since 15 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige zakelijke dienstverlening, neg
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering